Testing effectiveness (Phase 2)Ended earlyNCT04838860
What this trial is testing
Siltuximab In Siltuximab-RElapsed/REfractory Multicentric CAstleman Disease
Who this might be right for
Idiopathic Multicentric Castleman's Disease
RECORDATI GROUP 22
Showing 8 of 8 results